They expect their new shelf prospectus and reverse split to be completed on May 11. Based on last week's market cap, we would be looking at 35% dilution, but after yesterday's sell off, it is getting closer to 50%.
I had a buy box for a bounce play, but for the time being, I will be avoiding ACB like the plague. ACB and CGC, they once were kings of a promised land, and then, it all went bust. My money is safe with APHA, XLY, LABS, VLNS, and the USA based MSO's. Not with Acreage though. Perhaps I sound cynical, but this is a tough time for cannabis investors, and it requires a tough attitude and strong opinion. I act on what I see, not on what analysts tell me. One even suggests ACB is still a buy. Fundamentals and business strategy are key, and both CGC and ACB are lacking, for the time being.